Next Article in Journal
A Novel Framework for Inner-Outer Sustainability Assessment
Previous Article in Journal
The Medical Education Planetary Health Journey: Advancing the Agenda in the Health Professions Requires Eco-Ethical Leadership and Inclusive Collaboration
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Viewpoint

The Correlations among Dietary Lifestyle, Microecology, and Mind-Altering Toxoplasmosis on the Health of People, Place, and the Planet

by
Vanessa de Araujo Goes
1,2,*,
Yusuf Amuda Tajudeen
2,3,4 and
Mona Said El-Sherbini
2,5,*
1
LeBioME-Bioactives, Mitochondria and Placental Metabolism Core, Institute of Nutrition Josué de Castro, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
2
Member of the Nova Network, Baltimore, MD 21231, USA
3
Department of Microbiology, Faculty of Life Sciences, University of Ilorin, PG. 1515, Ilorin 240003, Nigeria
4
Department of Epidemiology and Medical Statistics, Faculty of Public Health, College of Medicine, University of Ibadan, P.M.B 5017 G.P.O, Ibadan 200212, Nigeria
5
Department of Medical Parasitology, Faculty of Medicine, Cairo University, Cairo 11562, Egypt
*
Authors to whom correspondence should be addressed.
Challenges 2022, 13(2), 63; https://doi.org/10.3390/challe13020063
Submission received: 23 August 2022 / Revised: 29 November 2022 / Accepted: 30 November 2022 / Published: 5 December 2022

Abstract

:
Being one of the most common foodborne protozoa worldwide, chronic toxoplasmosis caused by Toxoplasma gondii (T. gondii) could contribute significantly to the etiology of several mental disorders. The neurotropic parasite can directly influence the gut microbiota, causing inflammation with subsequent degradation of tryptophan required for parasite growth. Research in humans and animals shows that the gut microbiome is involved in the regulation of brain serotonergic pathways through the microbiota–gut–brain axis. Since the serotonin system is extensively interconnected with the body’s master clock through neuronal networks, the microbiota has been suggested as a potential mediator, fine-tuning circadian misalignment, following a reciprocal relationship with human eating patterns. Furthermore, adherence to an intermittent fasting diet can improve the serotonin biosynthesis pathway in the intestines and improve cognitive function. This review aims to explain the role of fasting in parasite-driven gut microbiome perturbation and the mechanisms by which Toxoplasma infection alters brain function. Due to its significant impact on social–economic status, diet patterns, microbiota disruption, circadian rhythm, chronic inflammation, and mental disorders, toxoplasmosis is an underestimated threat that could be prevented by simple lifestyle changes through educational actions. Furthermore, there are few research studies that address toxoplasmosis-induced mental disorders from a holistic perspective. Thus, a planetary health lens is needed to understand these correlations that directly relate to the promotion of a resilient and empathic civilization, crucial to enabling a flourishing healthy society on all scales.

1. Introduction

Being one of the most common foodborne parasitic infections worldwide, toxoplasmosis caused by Toxoplasma gondii represents a significant and emerging global public health burden [1]. Globally, an estimated 750 deaths are attributed to toxoplasmosis per year, and 50% of these deaths are related to eating meat contaminated with tissue cysts—the infective stage of toxoplasmosis [2,3]. The pathology and epidemiology of chronic toxoplasmosis emphasizes the relevant aspects of individual, place, and planet health and their correlation with anthropogenic driving factors. These macroecological factors contribute to the widespread transmission of toxoplasmosis infections with negative consequences on global mental health, as will be discussed in this article.
The obligatory intracellular tissue protozoan T. gondii has different routes of transmission during its life cycle since it is a heteroxenous and polyxenous parasite. Infective oocyst stages can be found in contaminated raw vegetables and unpasteurized milk, while viable tissue cyst stages can be found in undercooked meat, all of which can cause oral infection with toxoplasmosis. This directly renders some traditions around cultural eating habits a risk factor related to toxoplasmosis. Additionally, the ability of Toxoplasma tachyzoites stages to cross the placental barrier in IgM-positive pregnant women further exacerbates health risks in future generations through vertical transmission (transgenerational influence). Due to the different routes of transmission of toxoplasmosis—oral, hematogenous, transplacental—it is estimated to infect up to a third of the global population [1,4].
The onset of toxoplasmosis infection is often asymptomatic and therefore inadequately managed in most cases. However, serious health problems represent an underestimated threat, especially in neonates and immunosuppressed patients [4]. Once chronic/latent toxoplasmosis is established as indicated by seropositivity of anti-toxoplasma IgG antibodies, the tissue cyst stages detected in the brain and skeletal muscles can persist for life in humans, who act as an intermediate host in the parasite cycle. The first report on the correlation between latent toxoplasmosis and human cognitive function alteration was in 1953 [5]; in the following decades, more evidence was gathered through controlled behavioral analysis in humans and experimental animal models that reported mental alterations and host behavior change, psychiatric disorders, and neuropathies, to mention just a few [6,7,8]. The mechanisms of neuropathology vary in chronic toxoplasmosis of the brain, which has been reported to be due to brain inflammation, hormonal and neurotransmitter changes, or both [9]. The implications of mental health disorders caused by toxoplasmosis in our society and global healthcare systems can be significantly underestimated given their widespread prevalence worldwide.
Toxoplasmosis has a complex pathogenesis; following a foodborne infection, at the tachyzoite stage, it replicates in the enterocytes of the human gut. This stimulates the production of pro-inflammatory cytokines, chemokines, and immune mediators that disrupt the immune system [10]. This microecological inflammatory status leads to bacterial dysbiosis, immune-mediated tissue damage, and inflammation in the intestinal tract [11]. Furthermore, the Toxoplasma parasite itself alters different neurotransmitter metabolism and signaling such as dopamine, glutamate, γ-aminobutyric acid (GABA), and serotonin [12]. The intracellular nature of Toxoplasma tachyzoites stimulates different immune responses, yet the interactions with the gut microbiota need to be further elaborated [11,12]. Additionally, the gut–brain axis (GBA), a critical component of brain function and human behavior, is influenced by microbiome composition and diversity, a fact which has made substantial contributions to our understanding of the physical and mental health in a more integrated approach [11,13]. Hence, through this biochemical and physiological integration, the microbiome can be a key player in mitigating Toxoplasma infection, especially in the context of mental health.
Moreover, chronic brain infection with tissue cyst formation sustains the inflammatory response, leading to serotonin deficiency by shifting tryptophan metabolism. Tryptophan is an essential amino acid used for protein synthesis and is the sole precursor for the neuroendocrine transmitter serotonin and the pineal hormone melatonin [14]. There is evidence that changes in the composition of the gut microbiota affect GBA by modulating tryptophan metabolism [14]. Furthermore, products of tryptophan metabolism, such as serotonin, kynurenine, and indole compounds, are signaling molecules between gut microbiota and brain functions [15].
The gut microbiome plays a critical role in regulating host immunity not only through its key metabolic outputs, such as short chain fatty acids and tryptophan metabolites, but also via its interaction with the circadian rhythm [16,17], which is a central immune regulator. The bacterial community oscillates in composition, biophysical location, and function over a period of 24 h, driving rhythmic metabolic processes [18]. This intrinsic circadian machinery in the gut microbiota has many implications in host–microbiome interactions and, hence, on the entire function of the immune system.
Within the drivers of the microbiome, circadian variation (rhythmicity) is the timing of meals and the dietary composition, which is controlled by the host and influenced by the availability of food and social and cultural norms [19]. Microbiota itself can modulate the master clockwork machinery through its metabolic outputs.
There is evidence that the intermittent fasting regimen (IF) is associated with health benefits through different mechanisms [20]. The fasting/feeding dietary rhythm is suggested to stimulate the fluctuation of our gut microbiota and, therefore, a series of molecular alterations which in turn restore our inherent healthy circadian clock that has been disrupted by our superimposed anthropogenic lifestyle [21].
This article reviews the correlations among diet patterns, specifically intermittent fasting, the gut microbiome, circadian rhythm, and mental health in the context of toxoplasmosis, with an emphasis on the correlation between dietary lifestyle and foodborne illness. A holistic viewpoint from a micro- to a macro-ecological approach is highlighted in the following sections to understand the impact of toxoplasmosis on an individual, societal, and global level.

2. Lifestyle and Anthropogenic Drivers on Toxoplasma–Microbiome Microecology

Today, in the Anthropocene context, it is imperative to highlight the interdependency among lifestyle, ecosystems, and infectious disease. Despite ongoing infectious disease control programs, toxoplasmosis still accounts for 3 of the top 10 causes of death worldwide in the 21st century, especially in immunosuppressed populations [22]. Industrialization and modern society brought about a paradigm shift in lifestyle that led to misalignment in various pillars such as diet, exercise, sleep, mental well-being, and environmental exposure that has been associated with the burden of many diseases, including infectious ones [23]. Human activities, behaviors, and culture, including eating patterns, interfere with an individual’s ecosystem down to its microbial foundation [24]. At the same time, land use, food production, global trade, and travel are considered anthropogenic drivers of disease emergence, several of which are shared drivers of biodiversity loss, environmental degradation, and ecosystem disruption [23]. These scenarios facilitate the wide environmental spread of toxoplasmosis in different populations and age groups [24,25]. Growing evidence supports the potential role of the exposome concept (lifestyle and environmental exposures since birth) in the prevention or improvement of disease susceptibility [26].
On a microscale, the microbiota, characterized as a diverse set of microbes that colonize the human gut, represents the first line of resistance against any infection, including parasitic ones, modulating the susceptibility to and severity of infections through different mechanisms [27]. Protection against pathogen colonization is through niche exclusion and bacterial products that influence pathogen infectivity, its nourishment, and the release of microbiome-derived substances, all of which subsequently stimulate innate and adaptive immune responses [28]. Furthermore, some of these microbiota-derived metabolites curb infection through tryptophan breakdown products (indole and its derivatives) that modulate the mucosal barrier and enhance the host immune response. Thus, these neurochemical metabolites can inhibit pathogen growth and/or virulence pathways [27].
The development of infection signifies the crucial role of the microbiome in regulating the host physiology, as described by many scholars [17,27,29]. However, the combined internal infections and external factors such as lifestyle and anthropogenic exposomes that disrupt the microbiota’s function and diversity (dysbiosis) further interfere with the intrinsic immunological cascade, resulting in chronic inflammation and fulminant pathology depending on the immune system’s overall health [30].
At the epidemiological level, T. gondii tachyzoites are capable of infecting any nucleated cell, and almost all warm-blooded vertebrates can act as intermediate host for the parasite. On a demographic scale, its prevalence is dictated by social–economic status (hygiene, sanitation) and diet patterns. However, the interplay of the microbiota and circadian rhythm disruption, as well as chronic inflammation, all contribute to immune health and can be captured within the biopsychosocial aspect of the individual [31]. The modern lifestyle has influenced the structure–function relationship between the microbiota and infectious diseases in various ways [27]. For example, disruption of circadian rhythm is echoed in gut microbiome dysbiosis; therefore, this interdependency, which is influenced by many components of the exposome (sleep, diet), has an important, underestimated role in susceptibility to toxoplasmosis [32].
Additionally, since the microbiota modulates brain function by influencing serotonin metabolism, its disruption adds to the parasite tropism for the brain, which may increase mental disorders [15]. Hence, characterizing toxoplasmosis as an important disease within a holistic-systems-based perspective of planetary health can be insightful. Planetary health considers all natural and anthropogenic drivers of human health, physical and mental alike, calling for the promotion of a resilient and empathic civilization, which is crucial to enable a flourishing society [25].

3. Biochemical Correlations between Toxoplasmosis and Mental Health

Associations between toxoplasmosis and various neuropathies and psychiatric disorders have been reported in IgG seropositive patients with chronic toxoplasmosis. This includes behavioral changes and depression characterized by lower levels of serotonin [22]. Tryptophan, the precursor of serotonin, is essential for T. gondii growth. Biochemically, inflammation caused by T. gondii upregulates indoleamine-2,3-dioxygenase (IDO) and tryptophan-2.3-dioxygenase (TDO), leading to a catabolic tryptophan shunt related to depression. Furthermore, T. gondii infection activates the kynurenine pathway, resulting in high levels of neurotoxic metabolites such as kynurenic acid (KYNA) and quinolinic acid (QUIN). High levels of KYNA influence dopamine and glutamate levels, altering cognitive functions [22]. Recent studies suggest that toxoplasmosis disrupts the activity of the hypothalamic–pituitary–adrenal gland axis [9] and hormonal disorders, including serotonin, which could lead to behavioral disorders [22,33].
The gut–brain axis (GBA) is a bidirectional communication network between the gastrointestinal tract (enteric nervous system) and the central nervous system. Studies in animal models indicate that the gut microbiota can metabolize tryptophan, affecting its availability to the host, as well as its products, such as serotonin, kynurenine, tryptamine, and indole compounds, which have effects on this complex crosstalk [31,34]. Changes in the gut microbiota composition affect the GBA through modulation of tryptophan metabolism, including serotonin synthesis and the degradation pathway of the host, such as kynurenine with consequences for brain function [35]. Shao et al. [36] showed that T. gondii infection alters gut microbes in mice, suggesting that the gut microbiome alters disease progression. Manipulation of the gut microbiota could be a good strategy to balance tryptophan metabolism and its availability to the host (Supplementary Materials File).

4. Dietary Patterns as a Tool to Mitigate Toxoplasmosis

Circadian rhythm or chronobiology is a field of science that integrates the 24 h physiological changes to natural day and night cycles governed by planet Earth’s rotation [16]. Although the circadian pattern in human immune cells and hormonal regulation is basically cell-autonomous, infection and environmental factors such as light, temperature, exercise, as well as the dietary fasting/feeding cycle, significantly affect it [20]. Concurrently, the intrinsic circadian master clock of the host is correlated with the peripheral rhythmicity of the gut microbiota [20]. Similarly, the gut microbiota is characterized by interindividual variability due to genetic and environmental factors [35]. Diet is one of the individual extrinsic factors that has a strong influence on gut microbiota composition [37], as well as on the overall regulation of circadian rhythm, mainly through food composition and timing [38]. These delicate interconnections, namely diet, circadian rhythm, and gut microbiota [39,40], are affected by significant changes due to an anthropogenic lifestyle [38]. Behavioral dietary patterns have shifted towards a culture of overconsumption, especially of processed meat, ultraprocessed products, and refined carbohydrates, together with low consumption of vegetables, fruits, grains, and natural whole foods rich in fibers, micronutrients, and bioactive compounds, all of which is grossly reflected in the health and diversity of the gut microbiome to a large extent [37].
A dietary regime involving intermittent fasting is characterized by periods of food abstinence that are longer than the overnight fast [38]. It can be divided into three different patterns: alternate day fasting, whole day fasting, and time-restricted feeding [38]. Food timing modulation through intermittent fasting has been shown to affect the gut microbial population [41,42] through different mechanisms, such as increasing microbiome β-diversity and changing its microbial composition as well as the levels of its metabolites [43,44]. Increased plasma levels of serotonin, tryptophan, bile acids, and short-chain fatty acids (acetate butyrate and propionate) are among the metabolites modulated by the abundance of bacteria in the gut after intermittent fasting [44].
Since circadian rhythmicity modulates every aspect of any living organism, including bacteria from the intestinal microbiome, as well as the single-celled protozoa that inhabit host brain tissues, such as T. gondii [45], a time-restricted feeding regimen can restore the diurnal rhythmicity and compositional and functional structures of the intestinal microbiome over the course of the day [38,46,47].
Another aspect of intermittent fasting practices that is related to positive results is calorie restriction, which has been reported to promote various health benefits, including modulation of the immune response through activation of autophagy that improves immunity to fight infection [48]. Furthermore, fasting/feeding cycles activate different metabolic pathways that regulate rhythmic transcriptomes and thus translate into healthier phenotypes [20]. Being an important modulator of circadian rhythm, metabolic pathways, as well as the immune system, diet could be an interesting strategy to mitigate toxoplasmosis disease outcomes (Supplementary Materials File). The impact of intermittent fasting on alimentation is obvious, yet continued research on the therapeutic benefit of such an intervention in reducing the overall psychological morbidity due to toxoplasmosis is still needed to elucidate such correlations in human studies.

5. Conclusions

The neurotropic predilection of Toxoplasma gondii has received little attention in the global context of mental health, although with a worldwide prevalence. Mental disorders induced by latent toxoplasmosis are caused by the presence of T. gondii tissue cysts in the brain, which can persist for years. Insights into the foodborne nature of toxoplasmosis and the mechanisms of parasite manipulation through dietary patterns while integrating the biochemical and microbiota role are worth further investigations. It is imperative to adopt a holistic approach to understand toxoplasmosis in its microecology and pathophysiology. Adopting a holistic approach such as planetary health to address the interconnected challenges of toxoplasmosis linked to lifestyle risk factors will allow for appropriate design of baseline data of the occurrence of the disease at the interface between humans, animals, and the environment—which will allow for adequate and effective decisions for disease control and management.
The widespread nature of toxoplasmosis calls for addressing culture and lifestyle, education, and preventive measures as powerful tools to overcome this mental health threat. Strategies such as examining the relational values of the micro- and macroenvironment and promoting healthy dietary habits and patterns, along with good hygienic practices coupled with robust surveillance studies and translational research on community-wide level, could significantly reduce the global burden of toxoplasmosis and promote the overall health of individuals and societies.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/challe13020063/s1, Figure S1: Gut-Microbiome-Brain-Circadian rhythm interconnections. The neuro-immuno-endocrine adaptative systems. The entry of the parasite into the intestinal tract leads to dysbiosis and inflammation [11], disrupting the immune system as well as brain function through the gut-brain axis (GBA). Toxoplasma infection leads to serotonin and melatonin biosynthesis disruption through a tryptophan catabolic shunt. Furthermore, the gut microbiota have an intrinsic circadian machinery which rhythmicity is driven by, among other things, the timing of meals and the dietary composition Microbiota itself can modulate the master clockwork, interacting with the neuro-immune-endocrine systems.

Author Contributions

Conceptualization, V.d.A.G. and M.S.E.-S.; methodology, V.d.A.G., Y.A.T. and M.S.E.-S.; data curation, V.d.A.G., Y.A.T. and M.S.E.-S.; writing—original draft preparation, V.d.A.G., Y.A.T. and M.S.E.-S.; writing—review and editing, supervision, M.S.E.-S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Acknowledgments

The abstract of this article was presented at the 2021 International inVIVO Planetary Health Conference. We are grateful to the organizers and audience for their suggestions and comments, which have helped in improving the quality of the manuscript. We also acknowledge and thank the reviewers and editors of the Challenges journal for their effort in enriching this manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. World Health Organization; Food and Agriculture Organization of the United Nation. Multicriteria-Based Ranking for Risk Management of Food-Borne Parasites: Report of a Joint FAO/WHO Expert Meeting, 3–7 September 2012; FAO: Rome, Italy, 2014. [Google Scholar]
  2. Centers for Disease Control and Prevention. Preventing Congenital Toxoplasmosis. Available online: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr4902a5.htm (accessed on 16 August 2022).
  3. Hussain, M.A.; Stitt, V.; Szabo, E.A.; Nelan, B. Toxoplasma gondii in the Food Supply. Pathogens 2017, 6, 21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Johnson, K.S.; Johnson, P.T. Toxoplasmosis: Recent Advances in Understanding the Link Between Infection and Host Behavior. Annu. Rev. Anim. Biosc. 2021, 9, 249–264. [Google Scholar] [CrossRef] [PubMed]
  5. Burkinshaw, J.; Kirman, B.H.; Sorsby, A. Toxoplasmosis Is in Relation to Mental Deficiency. Br. Med. J. 1953, 4812, 702–704. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Sutterland, A.L.; Fond, G.; Kuin, A.; Koeter, M.W.; Lutter, R.; van Gool, T.; Yolken, R.; Szoke, A.; Leboyer, M.; de Haan, L. Beyond the Association. Toxoplasma gondii in Schizophrenia, Bipolar Disorder, and Addiction: Systematic Review and Meta-Analysis. Acta Psychiatr. Scand. 2015, 132, 161–179. [Google Scholar] [CrossRef] [PubMed]
  7. Soleymani, E.; Faizi, F.; Heidarimoghadam, R.; Davoodi, L.; Mohammadi, Y. Association of T. gondii Infection with Suicide: A Systematic Review and Meta-Analysis. BMC Public Health 2020, 20, 766. [Google Scholar] [CrossRef] [PubMed]
  8. Postolache, T.T.; Wadhawan, A.; Rujescu, D.; Hoisington, A.J.; Dagdag, A.; Baca-Garcia, E.; Lowry, C.A.; Okusaga, O.O.; Brenner, L.A. Toxoplasma gondii, Suicidal Behavior, and Intermediate Phenotypes for Suicidal Behavior. Front. Psychiatry 2021, 12, 665682. [Google Scholar] [CrossRef] [PubMed]
  9. Tedford, E.; McConkey, G. Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection. Pathogens 2017, 6, 19. [Google Scholar] [CrossRef] [Green Version]
  10. Madireddy, S.; Chacon, E.D.R.; Mangat, R. Toxoplasmosis; Bookshelf ID: NBK563286; StatPearls Publishing LLC: Treasure Island, FL, USA, 2022. Available online: https://www.ncbi.nlm.nih.gov/books/NBK563286/ (accessed on 15 October 2022). [PubMed]
  11. Snyder, L.M.; Denkers, E.Y. From initiators to Effectors: Roadmap through the Intestine During Encounter of Toxoplasma gondii with the Mucosal Immune System. Fornt. Cell. Infect. Microbiol. 2021, 11, 614701. [Google Scholar] [CrossRef]
  12. Tyebji, S.; Seizova, S.; Hannan, A.J.; Tomkin, C.J. Toxoplasmosis: A pathway to neuropsychiatric disorders. Neurosci. Biobehav. Rev. 2019, 96, 72–92. [Google Scholar] [CrossRef]
  13. O’Mahony, S.M.; Clarke, G.; Borre, Y.E.; Dinan, T.G.; Cryan, J.F. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res. 2015, 15, 32–48. [Google Scholar] [CrossRef]
  14. Lukic, I.; Getselter, D.; Koren, O.; Elliot, E. Role of Tryptophan in Microbiota-induced Depressive-Like Behavior: Evidence From Tryptophan Depletion Study. Front. Behav. Neurosci. 2019, 4, 123. [Google Scholar] [CrossRef] [Green Version]
  15. Gao, K.; Mu, C.L.; Farzi, A.; Zhu, H.Y. Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain. Adv. Nutr. 2020, 11, 709–723. [Google Scholar] [CrossRef]
  16. Wang, H.; Zhang, H.; Su, Y. New Insights into the Diurnal Rhythmicity of Gut Microbiota and Its Crosstalk with Host Circadian Rhythm. Animals 2022, 12, 1677. [Google Scholar] [CrossRef]
  17. Sherwin, E.; Dinan, T.G.; Cryan, J.F. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann. N. Y. Acad. Sci. 2018, 1420, 5–25. [Google Scholar] [CrossRef]
  18. Butler, T.D.; Gibbs, J.E. Circadian Host-Microbiome interactions in Immunity. Front. Immunol. 2020, 14, 1783. [Google Scholar] [CrossRef]
  19. Asher, G.; Corsi, P.S. Time for food: The interplay between nutrition, metabolism, and the circadian clock. Cell 2015, 26, 84–92. [Google Scholar] [CrossRef] [Green Version]
  20. Hu, D.; Xie, Z.; Ye, Y.; Bahijri, S.; Chen, M. The beneficial effects of intermittend fasting: And update on mechanism, and the role of circadian rhythm and gut microbiota. Hepatobiliary Surg. Nutr. 2020, 9, 597–602. [Google Scholar] [CrossRef]
  21. Zeb, F.; Wu, X.; Fatima, S.; Zaman, M.H.; Khan, S.A.; Safdar, M.; Alam, I.; Feng, Q. Time-restricted feeding regulates molecular mechanisms with involvement of circadian rhythm to prevent metabolic diseases. Nutrition 2021, 89, 111244. [Google Scholar] [CrossRef]
  22. Daher, D.; Shaghlil, A.; Sobh, E.; Hamie, M.; Hassan, M.E.; Moumneh, M.B.; Itani, S.; Hajj, R.E.; Tawk, L.; Sabban, M.E.; et al. Comprehensive Overview of Toxoplasma Gondii Induced and Associated diseases. Pathogens 2021, 20, 1351. [Google Scholar] [CrossRef]
  23. Graham, H.; White, P.C.L. Social determinants and Lifestyles: Integrating environmental and public health perspectives. Public Health 2016, 141, 270–278. [Google Scholar] [CrossRef]
  24. Machalaba, C.; Daszak, P.; Karesh, W.B.; Romanelli, C. Anthropogenic Drivers of Emerging infectious Diseases. In Global Sustainable Development Report; United Nations: New York, NY, USA, 2015. [Google Scholar]
  25. Prescott, S.L.; Logan, A.C.; Katz, D.A. Preventive Medicine for Person, Place, and Planet: Revisiting the Concept of High-Level Wellness in the Planetary Health Paradigm. Int. J. Environ. Res. Public Health 2019, 16, 238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Morales, J.S.; Valenzuela, P.L.; Garcia, A.C.; Butragueño, J.; Pavón, D.J.; Bastos, P.C.; Lucia, A. The Exposome and Immune Health in Times of the COVID-19 Pandemic. Nutrients 2021, 14, 24. [Google Scholar] [CrossRef] [PubMed]
  27. Tan, C.Y.; Ramirez, Z.E.; Surana, N.K. A modern world view of host-microbiota-pathogen interactions. J. Immunol. 2022, 207, 1710–1718. [Google Scholar] [CrossRef] [PubMed]
  28. Stecher, B.; Hardt, W.D. Mechanisms controlling pathogen colonization of the gut. Curr. Opin. Microbiol. 2011, 14, 82–91. [Google Scholar] [CrossRef] [PubMed]
  29. James, D.G. The Hunterian oration on louis Pasteur’s final judgement. Host reaction, soil or terrain. Trans. Med. Soc. Lond. 1982, 99–100, 131–147. [Google Scholar]
  30. Cohen, S.B.; Denkers, E.Y. Border maneuvers: Deployment of mucosal immunedefenses against Toxoplasma gondii. Mucosal Immunol. 2014, 7, 744–752. [Google Scholar] [CrossRef] [Green Version]
  31. Prescott, S.L.; Wegienka, G.; Logan, A.C.; Katz, D.L. Dysbiotic drift and biopsychosocial medicine: How the Microbiome Links Personal, Public and Planetary Health. Biopsychosoc. Med. 2018, 12, 7. [Google Scholar] [CrossRef]
  32. Greco, C.M.; Sassone-Corsi, P. Personalized Medicine and Circadian Rhythms: Opportunities for Modern Society. J. Exp. Med. 2020, 217, e20200702. [Google Scholar] [CrossRef]
  33. Akaltun, I.; Kara, S.S.; Kara, T. The relationship between Toxoplasma gondii IgG antibodies and generalized anxiety disorder and obsessive-compulsive disorder in children and adolescents: A new approach. Nord. J. Psychiatry 2018, 72, 57–62. [Google Scholar] [CrossRef]
  34. Agus, A.; Planchais, J.; Sokol, H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe 2018, 23, 716–724. [Google Scholar] [CrossRef]
  35. Gao, K.; Pi, Y.; Mu, C.L.; Farzi, A.; Liu, Z.; Zhu, W.Y. Increasing carbohydrate availability in the hindgut promotes hypothalamic neurotransmitter synthesis: Aromatic amino acids linking the microbiota-brain axis. J. Neurochem. 2019, 149, 641–659. [Google Scholar] [CrossRef]
  36. Shao, D.Y.; Bai, X.; Tong, M.W.; Zhang, Y.Y.; Liu, X.L.; Zhou, Y.H.; Li, C.; Cai, W.; Gao, X.; Liu, M.; et al. Changes to the gut microbiota in mice induced by infection with Toxoplasma gondii. Acta Trop. 2020, 203, 105301. [Google Scholar] [CrossRef]
  37. Brown, K.; DeCoffe, D.; Molcan, E.; Gibson, D.L. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012, 4, 1095–1119. [Google Scholar] [CrossRef] [Green Version]
  38. Daas, M.C.; Roos, N.M. Intermittent fasting conributes to aligned circadian rhythms through interactions with the gut microbiome. Benef. Microbes 2021, 12, 147–161. [Google Scholar] [CrossRef]
  39. Parkar, S.G.; Kalsbeek, A.; Cheeseman, J.S. Potential Role for the Gut Microbiota in Modulating Host Circadian Rhythm and Metabolic Health. Microorganisms 2019, 31, 41. [Google Scholar] [CrossRef] [Green Version]
  40. Choi, H.; Rao, M.C.; Chang, E.B. Gut microbiota as a transducer of dietary cues to regulate host circadian rhythms and metabolism. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 679–689. [Google Scholar] [CrossRef]
  41. Patterson, R.E.; Sears, D.D. Metabolic effects of intermittent fasting. Annu. Rev. Nutr. 2017, 37, 371–393. [Google Scholar] [CrossRef] [Green Version]
  42. Kaczmarek, J.L.; Thompson, S.V.; Holscher, H.D. Complex interactions of circadian rhythms, eating behaviors, and the gastrointestinal microbiota and their potential impact on health. Nutr. Rev. 2017, 75, 673–682. [Google Scholar] [CrossRef]
  43. Beli, E.; Yan, Y.; Moldovan, L.; Vieira, C.P.; Gao, R.; Duan, Y.; Prasad, R.; Bhatwadekar, A.; White, F.A.; Townsend, S.D.; et al. Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice. Diabetes 2018, 67, 1867–1879. [Google Scholar] [CrossRef] [Green Version]
  44. Liu, Z.; Dai, X.; Zhang, H.; Shi, R.; Hui, Y.; Jin, X.; Zhang, W.; Wang, L.; Wang, Q.; Wang, D.; et al. Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment. Nat. Commun. 2020, 11, 855. [Google Scholar] [CrossRef]
  45. Zhuang, X.; Edgar, R.S.; McKeating, J.A. The role of circadian clock pathways in viral replication. Semin. Immunopathol. 2022, 44, 175–182. [Google Scholar] [CrossRef] [PubMed]
  46. Thaiss, C.A.; Levy, M.; Korem, T.; Dohnalová, L.; Shapiro, H.; Jaitin, D.A.; David, E.; Winter, D.R.; Gury-BenAri, M.; Tatirovsky, E.; et al. Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations. Cell 2016, 167, 1495–1510.e12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Thaiss, C.A.; Levy, M.; Suez, J.; Elinav, E. The Interplay between the Innate Immune System and the Microbiota. Curr. Opin. Immunol. 2014, 26, 41–48. [Google Scholar] [CrossRef] [PubMed]
  48. Hanna, M.A.; Rahman, M.A.; Rahman, M.S.; Sohag, A.A.M.; Dash, R.; Hossain, K.S.; Farjana, M.; Uddin, M.J. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction. Autophagy and immune resonse. Immunol. Lett. 2020, 226, 38–45. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

de Araujo Goes, V.; Tajudeen, Y.A.; El-Sherbini, M.S. The Correlations among Dietary Lifestyle, Microecology, and Mind-Altering Toxoplasmosis on the Health of People, Place, and the Planet. Challenges 2022, 13, 63. https://doi.org/10.3390/challe13020063

AMA Style

de Araujo Goes V, Tajudeen YA, El-Sherbini MS. The Correlations among Dietary Lifestyle, Microecology, and Mind-Altering Toxoplasmosis on the Health of People, Place, and the Planet. Challenges. 2022; 13(2):63. https://doi.org/10.3390/challe13020063

Chicago/Turabian Style

de Araujo Goes, Vanessa, Yusuf Amuda Tajudeen, and Mona Said El-Sherbini. 2022. "The Correlations among Dietary Lifestyle, Microecology, and Mind-Altering Toxoplasmosis on the Health of People, Place, and the Planet" Challenges 13, no. 2: 63. https://doi.org/10.3390/challe13020063

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop